KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Shares Outstanding (Weighted Average) (2016 - 2026)

TherapeuticsMD filings provide 17 years of Shares Outstanding (Weighted Average) readings, the most recent being $11574.0 for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 99.9% to $11574.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $11574.0, a 99.9% decrease, with the full-year FY2025 number at $11.6 million, changed 0.32% from a year prior.
  • Shares Outstanding (Weighted Average) hit $11574.0 in Q1 2026 for TherapeuticsMD, down from $11.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $11.6 million in Q3 2025 to a low of $10441.0 in Q4 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $10.2 million (2023), compared with a mean of $9.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 110349.19% in 2024 and later plummeted 99.9% in 2026.
  • TherapeuticsMD's Shares Outstanding (Weighted Average) stood at $9.0 million in 2022, then crashed by 99.88% to $10441.0 in 2023, then skyrocketed by 110349.19% to $11.5 million in 2024, then grew by 0.32% to $11.6 million in 2025, then crashed by 99.9% to $11574.0 in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $11574.0 (Q1 2026), $11.6 million (Q4 2025), and $11.6 million (Q3 2025) per Business Quant data.